Tumour volume and weight were significantly reduced in mice treated with shikonin. The expression levels of RIP1, RIP3, γ-H2AX and phosphorylated ATM were significantly upregulated in the tumour tissues of the shikonin-treated group. Here, H2AX is linked to neoplasm.